Heidelberg, Germany · Founded 2015 · Privately Held (backing)
Developer of antitussive medication designed to address both the neurological and psychological aspects of behavioral and psychological symptoms. Exciva is based in Heidelberg, Germany and was founded in 2015. Its last reported valuation was $16.4 million in Oct 2021. It has raised $70.1 million.
Last reported valuation
$16.4M
Oct 2026
Priced at
—
Total raised
$70.1M
Last round
—
Team — not yet on record
No current team members for Exciva are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Exciva with a free account
·Watch Exciva: the Monday email on marks, rounds and moves
